-
Article | 2020.06.16
Randomized trial of Covid-19 chemoprophylaxis in healthcare professionals
Objective: To determine whether a two months treatment with hydroxychloroquine (HCQ) or Lopinavir / ritonavir (LPV / r) reduces the incidence of symptomatic or asymptomatic infections with SARS-CoV-2, compared to their placebo, in healthcare professionals exposed to the virus.In the absence of specific antiviral treatment, particular attention must be paid to prevention. Individual protective...
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...
-
Document de presse | 2024.04.26
WHO and France convene high-level meeting to defeat meningitis
Paralympians join effort to tackle deadly diseaseGlobal leaders highlight the need to defeat meningitis – a leading cause of disability – at a high-level meeting co-hosted by the World Health Organization (WHO) and Government of France, under the High Patronage of Emmanuel Macron, President of the French Republic. The event is taking place on 26-27 April 2024 at the Institut Pasteur and is...
-
Article | 2024.04.30
Émile Roux, savior of children
In 1878, Louis Pasteur was looking for a physician to help him study contagious diseases. His associate Émile Duclaux introduced him to a former student of his – Émile Roux – who quickly came into the orbit of the famous scientist. The young physician was 25, Pasteur was 56.
-
News | 2021.10.18
The replay of the conference "COVID-19, Advances and Remaining Challenges" is available
For three days, worldwide specialists shared their views about the pandemic during a congress hosted by the Institut Pasteur. Their contributions are to be found online.
-
Article | 2019.06.25
Infectious diseases emergence and transmission dynamics (23 entities)
This thematic area explores the process of infectious disease emergence through its biological and epidemiological components, including the crossing of the species barrier, pathogen identification, transmission dynamics, and epidemic surveillance and monitoring.
-
Vidéo | 2025.04.04
Debunking meningitis
Meningitis: warning signs!200 cases in France since January? Yes, but... This figure concerns invasive meningococcal infections, a 25-year record. But not all of them are meningitis!Dr Samy Taha, medical researcher at the CNR des Méningocoques, reminds us of the importance of prevention and rapid screening to limit serious forms of the disease.Symptoms to watch out for :High fever and intense...
-
Vidéo | 2025.04.24
Goodbye allergic asthma?
Every spring, the same battle: allergic asthma poisons the lives of millions of people.This form of asthma, triggered by allergens such as pollen, dust mites or animal hair, accounts for around 50% of asthma cases worldwide.As well as causing respiratory discomfort, it has a lasting impact on quality of life, and remains difficult to control, particularly in its severe forms.Today, the treatments...
-
Vidéo | 2025.06.10
Avian flu: should we be worried?
Avian flu is all over the news... but what is the real risk to humans?Marie-Anne Welti, head of the Molecular Mechanisms of Pneumovirus Multiplication unit at the Institut Pasteur, takes stock of the current situation.The H5N1 virus, responsible for avian flu, mainly affects birds, but has also been detected in farmed mammals, such as dairy cows in the USA since 2024.In France, cases were...
-
Fiche maladie | 2026.01.16
Marburg virus disease
Marburg virus disease is a rare hemorrhagic fever that is particularly severe for humans. The average case fatality rate is around 50%. The virus was named after the German town of Marburg, where the infectious agent was first identified in 1967 in imports of infected non-human primates from Uganda. Marburg virus is under constant global surveillance by the World Health Organization because of...